Dabur India Limited — FDA Class II (D-0630-2026)

Dabur India Limited is recalling 2,503 tubes of their drug due to CGMP deviations. This recall is classified as a safety issue. The recall affects products distributed in the U.S.

• •Dabur India Limited is recalling 2,503 tubes of their drug.
• •The recall is due to CGMP deficiencies.
• •This is classified as a Class II recall.
• •Consumers should stop using the product immediately.
• •Recalls like this can lead to increased regulatory scrutiny.

Consumers who purchased these 2,503 tubes should stop using the product due to CGMP deficiencies that could affect safety.